Pfizer - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
PFE
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world's best-known consumer healthcare brands. Every day, our colleagues work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of our time. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, visit www.pfizer.com. For additional information on our guidelines, please visit
Free Access to BioWorld Coronavirus Articles
Baseline Debuts To Challenge GLP-1 Giant Lilly in Alcohol Use Disorder
TandemAI Closes $22M Series A Extension Round
Roche Breast Cancer Prospect Fails First-Line Test, Shares Fall
Will Pfizer’s Lyme Disease Gamble Pay Off or Set the Space Back?
Biotech in 2025: A Retrospective
Ruder Finn Launches "What's Next" Podcast to Examine the Future of Marketing, Media, and Leadership in an AI Driven Era
Pfizer’s Early Metsera Data Leaves Analysts Wanting More
Judge Approves Pfizer, SEC Settlement Tied to Insider Trading at Cohen Hedge Fund
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Shows Strong Efficacy in Phase III Trial
Breast Cancer Treatments Heat Up: Six Therapies Poised to Transform Patient Outcomes
Servier Signs €1bn-Plus AI Pact with Iktos
Pfizer Shares Edge Higher on Strong Oncology Data Amid Flat 2026 Revenue Guidance
Is a ‘Genuinely Held’ Political Belief Enough for a Vaccine Exemption?
Pfizer Searches for Novel Tumor-Selective Antigens With $865M+ Cartography Pact
AstraZeneca Leads Big Pharma’s AI Clinical Trials Revolution with Real-World Patient Impact
Procedural Complaints: Raising Procedural Issues in CMA Cases
Pfizer, BioNTech to Pause COVID Vaccine Study Due to Low Enrollment
Madrigal Eyes Combination MASH Therapy with Pfizer Deal
Roche Raises NC Manufacturing Investment to $2B To Support Obesity Challenge
MindImmune Therapeutics Closes $10.2M Series A Extension; Brings Round Total to $30M
STAT+: Pfizer’s Lyme Vaccine Results Set up Tricky Regulatory Path
Dr. Vinay Prasad “Called For” RCTs. Dr. Peter Marks Delivered Them.
‘Almost Like a Religion’: Pfizer CEO Slams RFK Jr.’s 'Anti-Science' Vaccine Policies
Lipocine's Postpartum Depression Drug Fails; AstraZeneca Claims Liver Cancer Win
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
Trump Administration Sets up to 100% Tariffs on some Imported Drugs, with Many Companies Exempt
Lightspeed Selects 4 Deeptech Startups for Its India Ascends 2026 Cohort
The FDA’s Proposed “Black Box” Warning for COVID-19 Vaccines
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus
Gepotidacin
The Top 10 PharmTech Videos of 2025
Dr. Vinay Prasad Said He Would Deliver New COVID Vaccine RCTs. He Failed and Should STFU.
Pfizer Makes $530M Vaccine Play With Novavax Deal After Rumors of BioNTech Pullback
Proteasomes: A Novel Approach to Target the Immune System
French Biotech Enodia Gets €20.7M Aided by Pfizer for Protein Degrader Work
CMS's Medicare Price Negotiations Start Round Three
TrumpRx Delayed Amid Potential Anti-Kickback Concerns
Obesity Data, Kymera and FDA Sentiment Survey Results — a BioCentury Podcast
Book Briefing: ‘Genius at Scale’ by Linda A. Hill, Emily Tedards, and Jason Wild
STAT+: Pharmalittle: We’re Reading About Iran War’s Impact on Pharma Supply Chain, a Pfizer Lyme Vaccine, and More
Report Says MSD Is in Talks to Buy Revolution Meds
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
Boltz PBC Launches with $28M to Democratize AI Platforms for Drug Discovery
Keytruda and Padcev Could Become Cancer’s Power Couple
SPRY Therapeutics Secures FDA Label Expansion for Needle‑Free Epinephrine Spray
Lilly’s Triple Agonist Contender for Best-in-Class Weight Loss
WPP Media Appoints Nancy Lan to Lead Mindshare Sydney Client Portfolio
Shionogi Enters $2.5 Billion Agreement to Acquire All Rights to Radicava
MindImmune Therapeutics Secures $10.2M Series A Extension, Total Funding Reaches $30M
Crossbow Therapeutics Raises $77M in Series B Funding
French Biotech Enodia Therapeutics Raises €20.7M with Pfizer Backing
Mission Therapeutics Raises $13.3M From Existing Strategic Investors
FoRx Therapeutics Secures $50M Series A to Advance Precision Cancer Drug
